Clinical Trial

A Clinical Trial to Investigate the Acute Effect of Bragg Apple Cider Vinegar Supplement on Blood Glucose Control in a Healthy Adult Population

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to evaluate the efficacy of a Bragg ACV supplement on postprandial glucose excursion compared to a placebo following a standardized acute carbohydrate load. Participants will be asked to consume an apple cider vinegar supplement 10 minutes prior to a standardized meal.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-07-28; most recent amendment 2026-01-08.
Trial Details
NCT Number NCT07100977
Lead Sponsor Bragg Live Food Products
Collaborators: KGK Science Inc.
Conditions Postprandial Glucose, Blood Glucose Concentration
Enrollment 24 participants
Start Date 2026-01
Primary Completion 2026-01 (estimated)
Study Completion 2026-02 (estimated)
Updated on ClinicalTrials.gov 2026-01-09